Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 20, 2003BloodOpen Access

Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis

View Full Paper
Ask AI
Bookmark
Share

Authors

ADAnders Erik Astrup DahmUniversity of OsloAVAstrid van Hylckama VliegLeiden University Medical CenterBjørn BendzBjørn BendzInterventional / Structural Cardiology

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dahm et al. (2003) studied this question.

synapsesocial.com/papers/6a6de09f75498292b70802f1https://doi.org/10.1182/blood-2002-10-3188
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hormone replacement therapy and acquired resistance to activated protein C: results of a randomized, double‐blind, placebo‐controlled trial2001 · 93 citations
  2. 2C-399T Polymorphism in the Promoter Region of Human Tissue Factor Pathway Inhibitor (TFPI) Gene Does not Change the Plasma TFPI Antigen Level and Does not Cause Venous Thrombosis1998 · 33 citations
  3. 3Low Levels of Heparin-releasable Tissue Factor Pathway Inhibitor in Young Patients with Thrombosis1999 · 60 citations
  4. 4The 536C→T Transition in the Human Tissue Factor Pathway Inhibitor (TFPI) Gene Is Statistically Associated with a Higher Risk for Venous Thrombosis1999 · 72 citations